-+ 0.00%
-+ 0.00%
-+ 0.00%

32 BIOSCIENCES TO LAUNCH $40 MLN SERIES A AT J.P. MORGAN TO ADVANCE FIRST-IN-CLASS GI MUCOSAL-IMMUNE THERAPEUTICS

Reuters·01/08/2026 13:16:54

Please log in to view news